Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: Br J Haematol. 2014 Jan 27;165(3):358–363. doi: 10.1111/bjh.12753

Table II.

Treatment administered

Chemotherapy regimen administered
    CHOP 55 (72%)
    Hyper-CVAD 3 (4%)
    Other* 4 (5%)
    No chemotherapy 11 (14%)

Rituximab administered 47 (62%)

Radiation to the breast administered 48 (63%)

CNS prophylaxis administered 9 (12%)

Abbreviations: CHOP: cyclophosphamide, doxorubicin, vincristine, prednisone; CNS: Central Nervous System; CVAD: Cyclophosphamide, vincristine, doxorubicin, dexamethasone.

*

Other refers to non-anthracycline-based chemotherapy, such as CVP (cyclophosphamide, vincristine, prednisone).